Renal Podocyte Apoptosis in Zucker Diabetic Fatty Rats: Involvement of Methylglyoxal-Induced Oxidative DNA Damage

Journal of Comparative Pathology

Volumn 144, Issue 1, 2011, Pages 41-47

  Kim, J ^a   Sohn, E ^a   Kim, C S ^a   Kim, J S ^a  

^a Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Apoptosis; Diabetic nephropathy; Methylglyoxal; Oxidative stress; Podocyte

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; METHYLGLYOXAL;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DNA DAMAGE; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; WESTERN BLOTTING; ZUCKER DIABETIC FATTY RAT;

ANIMALS; APOPTOSIS; DEOXYGUANOSINE; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DNA DAMAGE; HYPERGLYCEMIA; IN SITU NICK-END LABELING; KIDNEY; MALE; OXIDATIVE STRESS; PODOCYTES; PYRUVALDEHYDE; RATS; RATS, ZUCKER;

ANIMALIA; RATTUS;

EID: 78650304156     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2010.04.008     Document Type: Article

References (40)

1. Akhand A.A., Hossain K., Mitsui H., Kato M., Miyata T., et al. Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells. Free Radical Biology and Medicine 2001, 31:20-30.
2. Amicarelli F., Colafarina S., Cattani F., Cimini A., Di Ilio C., et al. Scavenging system efficiency is crucial for cell resistance to ROS-mediated methylglyoxal injury. Free Radical Biology and Medicine 2003, 35:856-871.
3. Beckman K.B., Ames B.N. Oxidative decay of DNA. Journal of Biological Chemistry 1997, 272:19633-19636.
4. Beisswenger P.J., Howell S.K., O'Dell R.M., Wood M.E., Touchette A.D., et al. Alpha-dicarbonyls increase in the postprandial period and reflect the degree of hyperglycemia. Diabetes Care 2001, 24:726-732.
5. Brownlee M. Lilly Lecture 1993. Glycation and diabetic complications. Diabetes 1994, 43:836-841.
6. Burkle A. DNA repair and PARP in aging. Free Radical Research 2006, 40:1295-1302.
7. Cantero A.V., Portero-Otin M., Ayala V., Auge N., Sanson M., et al. Methylglyoxal induces advanced glycation end product (AGEs) formation and dysfunction of PDGF receptor-beta: implications for diabetic atherosclerosis. FASEB Journal 2007, 21:3096-3106.
8. Chan W.H., Wu H.J., Shiao N.H. Apoptotic signaling in methylglyoxal-treated human osteoblasts involves oxidative stress, c-Jun N-terminal kinase, caspase-3, and p21-activated kinase 2. Journal of Cellular Biochemistry 2007, 100:1056-1069.
9. Chuang P., Pedchenko V.K., Chetyrkin S.V., Ham A.L., Saleem M.A., et al. The effects of methylglyoxal (MGO) on podocytes. Matrix Biology 2006, 25:S81.
10. Cohen G.M. Caspases: the executioners of apoptosis. Biochemical Journal 1997, 326:1-16.
11. Coughlan M.T., Mibus A.L., Forbes J.M. Oxidative stress and advanced glycation in diabetic nephropathy. Annals of the New York Academy of Sciences 2008, 1126:190-193.
12. Dalla Vestra M., Saller A., Mauer M., Fioretto P. Role of mesangial expansion in the pathogenesis of diabetic nephropathy. Journal of Nephrology 2001, 14(Suppl. 4):S51-57.
13. de Zeeuw D., Remuzzi G., Parving H.H., Keane W.F., Zhang Z., et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney International 2004, 65:2309-2320.
14. Drummond K., Mauer M. The early natural history of nephropathy in type 1 diabetes: II. Early renal structural changes in type 1 diabetes. Diabetes 2002, 51:1580-1587.
15. Du J., Suzuki H., Nagase F., Akhand A.A., Ma X.Y., et al. Superoxide-mediated early oxidation and activation of ASK1 are important for initiating methylglyoxal-induced apoptosis process. Free Radical Biology and Medicine 2001, 31:469-478.
16. Fukami K., Yamagishi S., Ueda S., Okuda S. Role of AGEs in diabetic nephropathy. Current Pharmaceutical Design 2008, 14:946-952.
17. Fukunaga M., Miyata S., Liu B.F., Miyazaki H., Hirota Y., et al. Methylglyoxal induces apoptosis through activation of p38 MAPK in rat Schwann cells. Biochemical and Biophysical Research Communications 2004, 320:689-695.
18. Gorin Y., Block K., Hernandez J., Bhandari B., Wagner B., et al. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. Journal of Biological Chemistry 2005, 280:39616-39626.
19. Hale A.J., Smith C.A., Sutherland L.C., Stoneman V.E., Longthorne V.L., et al. Apoptosis: molecular regulation of cell death. European Journal of Biochemistry 1996, 236:1-26.
20. Huang W.J., Tung C.W., Ho C., Yang J.T., Chen M.L., et al. Ras activation modulates methylglyoxal-induced mesangial cell apoptosis through superoxide production. Renal Failure 2007, 29:911-921.
21. Khera T., Martin J., Riley S., Steadman R., Phillips A.O. Glucose enhances mesangial cell apoptosis. Laboratory Investigation 2006, 86:566-577.
22. Kim J., Son J.W., Lee J.A., Oh Y.S., Shinn S.H. Methylglyoxal induces apoptosis mediated by reactive oxygen species in bovine retinal pericytes. Journal of Korean Medical Science 2004, 19:95-100.
23. Kim Y.S., Kim J., Kim C.S., Sohn E.J., Lee Y.M., et al. KIOM-79, an inhibitor of AGEs-protein cross-linking, prevents progression of nephropathy in Zucker diabetic fatty rats. Evidence-Based Complementary and Alternative Medicine: eCAM 2009, 10.1093/ecam/nep078.
24. Lapolla A., Flamini R., Dalla Vedova A., Senesi A., Reitano R., et al. Glyoxal and methylglyoxal levels in diabetic patients: quantitative determination by a new GC/MS method. Clinical Chemistry and Laboratory Medicine 2003, 41:1166-1173.
25. Lee S.C., Han S.H., Li J.J., Lee S.H., Jung D.S., et al. Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditions. Kidney International 2009, 76:838-848.
26. Liu B.F., Miyata S., Hirota Y., Higo S., Miyazaki H., et al. Methylglyoxal induces apoptosis through activation of p38 mitogen-activated protein kinase in rat mesangial cells. Kidney International 2003, 63:947-957.
27. McLellan A.C., Thornalley P.J., Benn J., Sonksen P.H. Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications. Clinical Science 1994, 87:21-29.
28. Oba S., Hino M., Fujita T. Adrenomedullin protects against oxidative stress-induced podocyte injury as an endogenous antioxidant. Nephrology, Dialysis and Transplantation 2008, 23:510-517.
29. Pagtalunan M.E., Miller P.L., Jumping-Eagle S., Nelson R.G., Myers B.D., et al. Podocyte loss and progressive glomerular injury in type II diabetes. Journal of Clinical Investigation 1997, 99:342-348.
30. Pesce C., Menini S., Pricci F., Favre A., Leto G., et al. Glomerular cell replication and cell loss through apoptosis in experimental diabetes mellitus. Nephron 2002, 90:484-488.
31. Phillips S.A., Thornalley P.J. The formation of methylglyoxal from triose phosphates. Investigation using a specific assay for methylglyoxal. European Journal of Biochemistry 1993, 212:101-105.
32. Randell E.W., Vasdev S., Gill V. Measurement of methylglyoxal in rat tissues by electrospray ionization mass spectrometry and liquid chromatography. Journal of Pharmacological and Toxicological Methods 2005, 51:153-157.
33. Schafer S., Linz W., Bube A., Gerl M., Huber J., et al. Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats. Cardiovascular Research 2003, 60:447-454.
34. Sohn E.J., Kim C.S., Kim Y.S., Jung D.H., Jang D.S., et al. Effects of magnolol (5,5'-diallyl-2,2'-dihydroxybiphenyl) on diabetic nephropathy in type 2 diabetic Goto-Kakizaki rats. Life Science 2007, 80:468-475.
35. Susztak K., Raff A.C., Schiffer M., Bottinger E.P. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 2006, 55:225-233.
36. Thornalley P.J., Langborg A., Minhas H.S. Formation of glyoxal, methylglyoxal and 3-deoxyglucosone in the glycation of proteins by glucose. Biochemical Journal 1999, 344:109-116.
37. White K.E., Bilous R.W. Type 2 diabetic patients with nephropathy show structural-functional relationships that are similar to type 1 disease. Journal of the American Society for Nephrology 2000, 11:1667-1673.
38. Zeng J., Davies M.J. Evidence for the formation of adducts and S-(carboxymethyl)cysteine on reaction of alpha-dicarbonyl compounds with thiol groups on amino acids, peptides, and proteins. Chemical Research in Toxicology 2005, 18:1232-1241.
39. Zgheib O., Huyen Y., DiTullio R.A., Snyder A., Venere M., et al. ATM signaling and 53BP1. Radiotherapy and Oncology 2005, 76:119-122.
40. Ziyadeh F.N., Wolf G. Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Current Diabetes Reviews 2008, 4:39-45.